Compound Detail
CHEMBL2325903
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2325903 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YCFLEMHGWPQDSP-VIFPVBQESA-N |
5
Targets
7
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
286.4
MW (Da)
3.00
ALogP
3
HBA
2
HBD
70.7
PSA (Ų)
0.91
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 8.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK3 CHEMBL2148 | IC50 | 8.85 | 8.85 | 1.4 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 7.97 | 6.615 | 10.8 | 2 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | IC50 | 7.35 | 7.35 | 44.5 | 1 |
| JAK3/JAK1 CHEMBL3038491 | IC50 | 6.68 | 6.145 | 211.0 | 2 |
| JAK2/JAK1 CHEMBL3038492 | IC50 | 5.47 | 5.47 | 3380.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK3 | IC50 | = | 1.4 | nM | 8.85 | Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEY... | 23214979 |
| Tyrosine-protein kinase JAK2 | IC50 | = | 10.8 | nM | 7.97 | Inhibition of JAK2 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEY... | 23214979 |
| Tyrosine-protein kinase JAK1 | IC50 | = | 44.5 | nM | 7.35 | Inhibition of JAK1 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEY... | 23214979 |
| JAK3/JAK1 | IC50 | = | 211.0 | nM | 6.68 | Inhibition of JAK3/JAK1 in human PBMC expressing CD3 assessed as inhibition of I... | 23214979 |
| JAK3/JAK1 | IC50 | = | 2460.0 | nM | 5.61 | Inhibition of JAK3/JAK1 in human whole blood expressing CD13 assessed as inhibit... | 23214979 |
| JAK2/JAK1 | IC50 | = | 3380.0 | nM | 5.47 | Inhibition of JAK2/JAK1 in human PBMC expressing CD14 assessed as inhibition of ... | 23214979 |
| Tyrosine-protein kinase JAK2 | IC50 | = | 5480.0 | nM | 5.26 | Inhibition of JAK2 in human PBMC expressing CD14 assessed as inhibition of GM-CS... | 23214979 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23214979 | 10.1021/jm301646k | Unchecked | 4 |
| 23214979 | 10.1021/jm301646k | Tyrosine-protein kinase JAK2 | 2 |
| 23214979 | 10.1021/jm301646k | JAK3/JAK1 | 2 |
| 23214979 | 10.1021/jm301646k | Serine/threonine-protein kinase D2 | 1 |
| 23214979 | 10.1021/jm301646k | Tyrosine-protein kinase JAK3 | 1 |
| 23214979 | 10.1021/jm301646k | Hepatocyte growth factor receptor | 1 |
| 23214979 | 10.1021/jm301646k | Ribosomal protein S6 kinase alpha-5 | 1 |
| 23214979 | 10.1021/jm301646k | Serine/threonine-protein kinase 3 | 1 |
| 23214979 | 10.1021/jm301646k | Mitogen-activated protein kinase 14 | 1 |
| 23214979 | 10.1021/jm301646k | Ribosomal protein S6 kinase beta-1 | 1 |
| 23214979 | 10.1021/jm301646k | Serine/threonine-protein kinase PAK 2 | 1 |
| 23214979 | 10.1021/jm301646k | Serine/threonine-protein kinase pim-2 | 1 |
| 23214979 | 10.1021/jm301646k | Protein kinase C beta type | 1 |
| 23214979 | 10.1021/jm301646k | Protein kinase C zeta type | 1 |
| 23214979 | 10.1021/jm301646k | MAP kinase-activated protein kinase 5 | 1 |
| 23214979 | 10.1021/jm301646k | Rho-associated protein kinase 2 | 1 |
| 23214979 | 10.1021/jm301646k | Ribosomal protein S6 kinase alpha-1 | 1 |
| 23214979 | 10.1021/jm301646k | Serine/threonine-protein kinase Sgk1 | 1 |
| 23214979 | 10.1021/jm301646k | Proto-oncogene tyrosine-protein kinase Src | 1 |
| 23214979 | 10.1021/jm301646k | Tyrosine-protein kinase SYK | 1 |
Data from ChEMBL 36 via Core Engine